Fortress Biotech Inc. (FBIOP) Cash Flow Statement Analysis - Operating Cash Flow, CapEx & Free Cash Flow - Stocknear

Fortress Biotech Inc.

NASDAQ: FBIOP · Real-Time Price · USD
7.38
0.11 (1.51%)
At close: Oct 03, 2025, 3:59 PM
7.49
1.49%
After-hours: Oct 03, 2025, 04:00 PM EDT

Fortress Biotech Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-11.65M -24.69M -26.32M -12.87M -10.95M -39.02M -9.28M -10.72M -59.3M -55.15M -57.45M -53.06M -53.93M -49.48M -68.51M -45.86M -24.39M -26.07M
Depreciation & Amortization
1.16M 1.68M -1.24M -2.91M 1.19M 1.19M 1.71M 2.75M 1.18M 1.91M 2.59M 2.34M 2.22M 2.2M 1.68M 1.74M 1.77M 1.6M
Stock-Based Compensation
16.79M 6.29M 16.19M n/a 5M 4.86M 3.7M 4.38M 4.22M 4.73M 5.51M 6.84M 5.08M 5.56M 7.04M 4.33M 4.35M 3.77M
Other Working Capital
-624K 2.66M -4.57M 2.34M 2.13M -1.89M -4.43M -784K 549K 25K -4.05M -1.39M -378K 384K -3.33M -2.33M -1.28M 7.69M
Other Non-Cash Items
-27.08M 143K 4.19M 585K -13.89M 1.92M 7.93M 76K 2.82M -865K 490K 874K 1.01M 516K 4.5M 7.2M 12.08M 656K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -20.85M -5M 10.05M n/a n/a n/a n/a n/a 378K -12.13M -21.21M -5.84M
Change in Working Capital
-6.78M -2.98M -5.73M -4.87M -3.19M 5.67M -18.15M -8.26M 7.75M 6.15M 1.01M -267K 4.2M -5.66M 16.22M 23.03M -7.06M 4.19M
Operating Cash Flow
-27.56M -19.56M -12.91M -20.06M -21.84M -25.39M -34.94M -16.78M -33.29M -43.22M -47.84M -43.27M -41.42M -46.86M -38.7M -21.7M -34.46M -21.69M
Capital Expenditures
n/a n/a n/a n/a n/a n/a -63K -1M -34K n/a -391K -1.02M -307K -1.34M -3.51M -7.54M -4.84M -458K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a n/a n/a 5M -5M 20M -20M 20M n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
6.09M 1.17M -15M n/a n/a n/a -35K 5M -7M n/a -20M 20.13M -20M -20M 55.31M -7.08M -3.15M n/a
Investing Cash Flow
6.09M 1.17M -15M n/a n/a n/a -63K 5M -2.04M -5M -391K -893K -307K -21.34M 53.35M -7.54M -4.84M -458K
Debt Repayment
-4.93M -625K 5M -17.33M 5M n/a 14.62M -10M -43.47M 52K 2.95M 5M -17K 41.32M -10.45M -2.5M n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -371K n/a n/a n/a n/a
Dividend Paid
-166K -166K -166K -176K -2.18M -2.18M -2.19M -2.19M -2.19M -2.19M -2.19M -2.2M -2.2M -2.19M -2.19M -2.19M -2.01M -2.19M
Other Financial Acitivies
619K 116K -217K -160K -4.55M 4.76M 479K -889K 15.28M n/a -1.79M -627K n/a 12.54M 5.26M -170K -1.09M -3.2M
Financial Cash Flow
4.52M 52.14M 25.81M 2.71M 14.27M 27.86M 43.62M -2.69M -30.38M 22.19M 18.62M 3.75M 2.99M 49.96M 38.94M 6.97M 24.39M 78.69M
Net Cash Flow
-16.95M 33.74M -2.1M -17.35M -7.57M 2.47M 6.18M -14.46M -65.71M -26.03M -29.62M -40.42M -38.74M -18.23M 53.6M -22.27M -14.9M 56.55M
Free Cash Flow
-27.56M -19.56M -12.91M -20.06M -21.84M -25.39M -35M -17.78M -33.33M -43.22M -48.23M -44.29M -41.73M -48.2M -42.2M -29.24M -39.3M -22.15M